Pembrolizumab in hemodialysis patients. Is it safe? [electronic resource]
Producer: 20211001Description: 678-679 p. digitalISSN:- 2013-2514
- Adenocarcinoma, Clear Cell -- drug therapy
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antineoplastic Agents, Immunological -- adverse effects
- B7-H1 Antigen -- metabolism
- Bone Neoplasms -- drug therapy
- Glomerulonephritis, IGA -- therapy
- Graft Rejection -- immunology
- Humans
- Kidney Transplantation
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Peritoneal Dialysis
- Reoperation
- Ribs
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.